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Reduced activity of the growth-regulating TOR complex 1 induces transcription of many genes. In this issue
of Developmental Cell, Tiebe et al. (2015) identify a transcriptional regulator complex repressed by TORC1
and responsible for a vast majority of the observed transcriptional changes in Drosophila.Multicellular animals have to adjust their
growth and metabolism to the nutritional
status. Whereas favorable conditions
allow for anabolic processes, biomass
accumulation, and ultimately growth,
limiting conditions are endured by a
stress protection program. The systemic
regulation of the cellular behavior is
mainly achieved by insulin/insulin-like
growth factor signaling (IIS). Upon low
IIS activity, the protein kinase Akt/PKB is
not sufficiently active to phosphorylate
and thereby inactivate the transcription
factor FoxO, which in turnmounts a stress
response by activating the transcription of
a multitude of target genes.
Most of the growth-promoting effects
of IIS are mediated by the conserved
target of rapamycin complex 1 (TORC1)
centered around the protein kinase TOR.
TORC1 coordinates cellular growth with
nutritional conditions in eukaryotic cells.
It does so by orchestrating many core
cellular processes, including ribosome
biogenesis, translational initiation, and
autophagy. Besides direct phosphoryla-
tion of key regulators of translation initia-
tion, TORC1 also impacts on transcription
mediated by all RNA polymerases.
Recent research in cellular growth control
has mainly focused on the regulation of
TORC1 by amino acids (for the latest in-
sights, see Fawal et al., 2015; Jewell
et al., 2015; Rebsamen et al., 2015;
Wang et al., 2015). Transcriptional regula-
tion downstream of TORC1—and espe-
cially transcription induced by TORC1
inhibition—has remained a comparatively
uncharted area. An article by Tiebe et al.
(2015) in this issue of Developmental Cell
changes this situation by identifying
REPTOR and REPTOR-BP as transcrip-
tional regulators that are repressed by
TORC1 in themodel organismDrosophila.
REPTOR and REPTOR-BP were identi-
fied in an elegant and straightforwardassay. The authors used regulatory se-
quences of unkempt, a gene previously
shown to be induced by treating cultured
Drosophila S2 cells with the TORC1 inhib-
itor rapamycin (Guertin et al., 2006), to
generate a transcriptional reporter. This
reporter allowed screening for genes
required for transcriptional activation
upon low TORC1 activity. Probing of
more than 1,000 genes encoding putative
DNA-binding proteins by RNAi led to
the identification of two genes. Co-immu-
noprecipitation experiments confirmed
the earlier observation from a large
proteome-wide interaction study that the
two gene products physically interact
(Guruharsha et al., 2011), and the two pro-
teins were therefore dubbed REPTOR
(REPressed by TOR) and REPTOR-BP
(REPTOR-binding partner).
REPTOR-BP is a rather small protein of
118 amino acids, essentially consisting
of a basic region leucine zipper (BRLZ)
domain. The much larger REPTOR pro-
tein (814 amino acids) also carries a
BRLZ domain near its carboxy terminus,
which is required for the binding to
REPTOR-BP. A transactivation assay
demonstrated strong transactivation ca-
pacity of REPTOR but not of REPTOR-
BP. Furthermore, chromatin immunopre-
cipitation experiments revealed specific
binding of REPTOR to regulatory se-
quences of suspected target genes
(such as unkempt) upon rapamycin treat-
ment. By contrast, REPTOR-BP bound
chromatin more broadly and largely
independently of the TORC1 activation
status (although chromatin binding was
enhanced by rapamycin treatment).
To assess the importance of REPTOR
and REPTOR-BP in upregulating tran-
scription upon inhibited TORC1 activity,
Tiebe et al. interrogated the transcriptome
of S2 cells treated with rapamycin upon
knockdown of REPTOR or REPTOR-BP.Developmental CeWhereas rapamycin treatment resulted
in the upregulation of more than 200
genes in control cells, the loss of REPTOR
or REPTOR-BP blunted the upregulation
of roughly 90% of these genes. Thus,
the REPTOR/REPTOR-BP complex is
responsible for the expression of most
genes induced by TORC1 inhibition.
HowdoesTORC1 regulate theREPTOR/
REPTOR-BP complex? The interaction
of REPTOR and REPTOR-BP was unaf-
fected by the TORC1 activation status,
but TORC1 activity impinged on the
subcellular localization of REPTOR.
Under normal culture conditions, REPTOR
was predominantly cytoplasmic, but it
translocated to the nucleus upon TORC1
inhibition. The authors then presented
evidence consistent with the idea that
TOR directly phosphorylates two serine
residues in REPTOR that form a docking
site for 14-3-3 proteins, which mediate
cytoplasmic retention.
The regulation of REPTOR by TORC1 is
strikingly reminiscent of the mechanism
by which Akt/PKB inactivates the tran-
scription factor FoxO (Figure 1). Interest-
ingly, Tiebe et al. found that the most
enriched motif in DNA regions bound by
REPTOR-BP corresponds to the FoxO
binding motif. In fact, a large fraction of
the REPTOR target genes have previously
been shown to be FoxO targets (Teleman
et al., 2008), suggesting that FoxO and
REPTOR/REPTOR-BP bind the same
cis-regulatory regions. Genetic interac-
tions between FoxO and REPTOR are
consistent with the idea that the factors
collaborate in the cellular stress response:
although single mutants are viable (see
below), animals lacking both REPTOR
and FoxO die as larvae.
The study of REPTOR and REPTOR-BP
in Drosophila would not have been
complete without a thorough genetic
analysis. Knockout flies for both genesll 33, May 4, 2015 ª2015 Elsevier Inc. 245
Figure 1. Comparison of FoxO and REPTOR Regulatory Mechanisms
Phosphorylation of the FoxO (left) and REPTOR (right) transcriptional regulators by Akt/PKB and TORC1, respectively, promotes interaction with 14-3-3 proteins
and cytoplasmic retention. Upon nutrient deprivation, inhibition of IIS and/or TORC1 leads to translocation of the respective factors into the nucleus, resulting in
the activation of stress response genes.
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nation. An unkempt reporter transgene
served as a reliable readout for REPTOR
activity as its induction was abrogated
in REPTOR mutant flies. The reporter
revealed that nutritional limitation en-
hances REPTOR activity in all tissues,
both in larvae and in adults. To compare
the in vivo situation with the previous
analysis in cultured S2 cells, Tiebe et al.
established the expression profile of
wild-type and REPTOR mutant larvae
upon rapamycin feeding. About 90% of
the more than 400 genes induced by
TORC1 inhibition were dependent on
REPTOR. Many of those genes are in-
volved in stress response and metabolic
regulation. Surprisingly, a majority of the
genes downregulated upon rapamycin
feeding also turned out to be REPTOR
dependent, although whether this is a
direct effect remains unclear.
Under nutrient-rich conditions, larvae
do not need REPTOR/REPTOR-BP to
develop. This is not surprising, because
the larval stages are characterized
by massive cellular growth and high
TORC1 activity; REPTOR is thus con-
stantly repressed. The situation is dif-
ferent in non-growing adult flies. REPTOR
and REPTOR-BP knockout flies have
decreased lipid and glycogen stores and
are highly sensitive to starvation.REPTOR
also becomes limiting in larvae upon dilu-
tion of the food source. Furthermore, the
effects of genetically reducing TORC1
activity (reduced larval size and metabolic246 Developmental Cell 33, May 4, 2015 ª20abnormalities) are partially suppressed
by the loss of REPTOR, indicating that
TORC1 regulates not only metabolism
but—at least in part—also growth by
repressing REPTOR.
The current study by Tiebe et al. illumi-
nates many aspects of transcriptional
regulation downstream of TORC1. In an
admirable wealth of experiments, the
authors convincingly demonstrate the
importance of REPTOR/REPTOR-BP in
mediating most of the transcriptional
changes caused by TORC1 inhibition.
The authors propose that, whereas IIS-
mediated regulation of FoxO reflects
the impact of systemic nutrient signal-
ing, TORC1-dependent repression of
REPTOR/REPTOR-BP instead conveys
the cell-autonomous assessment of
nutrient abundance. Jointly, they ensure
that any nutrient shortage will evoke an
appropriate transcriptional response.
Even with this comprehensive analysis,
many questions remain to be addressed
in the future. For example, the role of the
constitutively nuclear REPTOR-BP in
assisting REPTOR is rather enigmatic.
Furthermore, the exact mechanism
of transcriptional regulation by the
REPTOR/REPTOR-BP dimer needs to
be determined. Tiebe et al. obtained first
indications that the recruitment of epi-
genetic factors may play a role. It also
remains to be proven that TOR directly
phosphorylates REPTOR. A major future
task will be to analyze the contributions
of the many FoxO and REPTOR/15 Elsevier Inc.REPTOR-BP targets to adapt metabolism
and to protect cells against nutritional
stress. Tissue specificity of target genes
and their functions may further compli-
cate this analysis.
Based on their sequence, REPTOR and
REPTOR-BP have homologs in humans
(Crebrf and Crebl2, respectively). It is a
safe bet that these proteins will attract
much attention in the near future.REFERENCES
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